Antiemetic efficacy of subcutaneous 5-HT3 receptor antagonists in terminal cancer patients

被引：0
|
作者：
Porcel, JM [1 ]
Salud, A
Porta, J
机构：
[1] Univ Lleida, Hosp Arnau Vilanova, Dept Internal Med, Lleida, Spain
[2] Univ Lleida, Hosp Arnau Vilanova, Dept Med Oncol, Lleida, Spain
[3] Univ Lleida, Hosp Arnau Vilanova, Palliat Care Unit, Lleida, Spain
[4] Univ Lleida, Hosp Arnau Vilanova, Div Pharmacol, Lleida, Spain
来源：
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT | 1998年 / 15卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：265 / 266
页数：2
相关论文
共 50 条
  • [1] MECHANISM OF THE ANTIEMETIC ACTIVITY OF 5-HT3 RECEPTOR ANTAGONISTS
    TYERS, MB
    FREEMAN, AJ
    [J]. ONCOLOGY, 1992, 49 (04) : 263 - 268
  • [2] SELECTIVITY OF 5-HT3 RECEPTOR ANTAGONISTS AND ANTIEMETIC MECHANISMS OF ACTION
    FREEMAN, AJ
    CUNNINGHAM, KT
    TYERS, MB
    [J]. ANTI-CANCER DRUGS, 1992, 3 (02) : 79 - 85
  • [3] THE DEVELOPMENT OF SELECTIVE 5-HT3 RECEPTOR ANTAGONISTS AS ANTIEMETIC AGENTS
    SANGER, GJ
    [J]. BRITISH JOURNAL OF CANCER, 1990, 62 (03) : 479 - 479
  • [4] THE ANTIEMETIC ACTIONS OF 5-HT3 RECEPTOR ANTAGONISTS ARE ENHANCED BY FENFLURAMINE
    COSTALL, B
    NAYLOR, RJ
    TATTERSALL, FD
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1988, 94 : P390 - P390
  • [5] ACUTE ANTIEMETIC EFFICACY AND SAFETY OF DOLASETRON MESYLATE, A 5-HT3 ANTAGONISTS, IN CANCER-PATIENTS TREATED WITH CISPLATIN
    CONROY, T
    CAPPELAERE, P
    FABBRO, M
    FAUSER, AA
    SPLINTER, TAW
    SPIELMANN, M
    SCHNEIDER, M
    CHEVALLIER, B
    GOUPIL, A
    CHAUVERGNE, J
    FARGEOT, P
    PREVOT, G
    OGRADY, P
    GREEN, D
    HARDENBERG, J
    BOYCE, M
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1994, 17 (02): : 97 - 102
  • [6] 5-HT3 antiemetic therapy for patients with breast cancer
    Perez, EA
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1999, 57 (02) : 207 - 214
  • [7] 5-HT3 receptor antagonists
    Silverstone, PH
    Greenshaw, AJ
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 1996, 6 (05) : 471 - 481
  • [8] 5-HT3 receptor antagonists
    Lloyd, AW
    [J]. DRUG DISCOVERY TODAY, 1997, 2 (05) : 206 - 206
  • [9] SITE(S) AND MECHANISMS OF THE ANTIEMETIC ACTION OF 5-HT3 RECEPTOR ANTAGONISTS - DISCUSSION
    TYERS, MB
    [J]. BRITISH JOURNAL OF CANCER, 1992, 66 : S12 - S13
  • [10] Receptor occupancy theory-based analysis of antiemetic effects and standard doses of 5-HT3 receptor antagonists in cancer patients
    Yamada, Y
    Sugiura, M
    Higo, K
    Ozeki, T
    Takayanagi, R
    Okuyama, K
    Yamamoto, K
    Satoh, H
    Sawada, Y
    Iga, T
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2004, 54 (02) : 185 - 190
12345